Drug information for BUTAZOLIDIN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 100MG Discontinued   PHENYLBUTAZONE Phenylbutazone NOVARTIS 8319
TABLET; ORAL 100MG Discontinued   PHENYLBUTAZONE Phenylbutazone NOVARTIS   "

Drug Adverse Effects information for BUTAZOLIDIN

Role code Indications Reaction # Reports
C ANAESTHESIA ANXIETY 1
C ANAESTHESIA ARRHYTHMIA SUPRAVENTRICULAR 1
C ANAESTHESIA IMPETIGO HERPETIFORMIS 1
C ANAESTHESIA PRINZMETAL ANGINA 1
C ANKYLOSING SPONDYLITIS CROHN'S DISEASE 1
C ANKYLOSING SPONDYLITIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C ANKYLOSING SPONDYLITIS WEIGHT DECREASED 1
C INTERMITTENT CLAUDICATION DIABETES MELLITUS INADEQUATE CONTROL 1
C INTERMITTENT CLAUDICATION SINUS TACHYCARDIA 1
C MUSCULOSKELETAL PAIN ANXIETY 2
C MUSCULOSKELETAL PAIN ARRHYTHMIA SUPRAVENTRICULAR 2
C MUSCULOSKELETAL PAIN IMPETIGO HERPETIFORMIS 2
C MUSCULOSKELETAL PAIN PRINZMETAL ANGINA 2
C NEPHROLITHIASIS ANXIETY 1
C NEPHROLITHIASIS ARRHYTHMIA SUPRAVENTRICULAR 1
C NEPHROLITHIASIS IMPETIGO HERPETIFORMIS 1
C NEPHROLITHIASIS PRINZMETAL ANGINA 1
C PAIN ANXIETY 1
C PAIN ARRHYTHMIA SUPRAVENTRICULAR 1
C PAIN IMPETIGO HERPETIFORMIS 1
C PAIN PRINZMETAL ANGINA 1
C PERIOSTITIS ANXIETY 1
C PERIOSTITIS ARRHYTHMIA SUPRAVENTRICULAR 1
C PERIOSTITIS IMPETIGO HERPETIFORMIS 1
C PERIOSTITIS PRINZMETAL ANGINA 1
C PROSTATIC ADENOMA CROHN'S DISEASE 2
C PROSTATIC ADENOMA GENERAL PHYSICAL HEALTH DETERIORATION 2
C PROSTATIC ADENOMA WEIGHT DECREASED 2
C SPONDYLITIS CROHN'S DISEASE 1
C SPONDYLITIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C SPONDYLITIS WEIGHT DECREASED 1
Ads by Google